ST3 ENT Interview Preparation – ClinicalJunior.com

A note from Professor Vik Veer

I wrote ClinicalJunior.com as an SHO in ENT, partly to help myself consolidate knowledge and partly to help other junior doctors. I have now been a Consultant ENT Surgeon for many years. I still care deeply about helping trainees succeed in getting onto ENT training programmes, so I have written this guide to give you a genuine insider's perspective on the ST3 application and interview process. Good luck — it is a competitive process, but it is very achievable with the right preparation.

For more resources, see my website, YouTube channel, and newsletter.

What is ST3 ENT?

ENT (Otolaryngology, Head and Neck Surgery) in the UK is a competitive specialty that requires a structured training pathway. The typical route is as follows:

Foundation Programme (FY1–FY2): Two years of broad clinical training. ENT is not routinely a foundation rotation but may be available in some programmes.
Core Surgical Training (CST, ST1–ST2): Two years of broad surgical training covering multiple specialties. The MRCS examination must be passed during or after CST. This is the most common entry point to ENT specialty training.
ST3 ENT: Competitive entry to ENT specialty training at ST3 level, following successful completion of CST (or equivalent). Training lasts until ST8 (CCT level). The National ENT Specialty Advisory Committee (SAC) and the Joint Committee on Surgical Training (JCST) oversee this training.
Certificate of Completion of Training (CCT): Awarded upon satisfactory completion of the full specialty training programme, typically at ST8. The FRCS (ORL-HNS) examination is a requirement before CCT.

Approximately 50–70 ST3 ENT posts are advertised nationally each year in England, with a variable number in Scotland, Wales, and Northern Ireland. Competition ratios have historically been in the range of 3:1 to 6:1, making preparation and portfolio quality critical.

Application Process and Timeline

Typical Timeline

November–December: Person specifications and application details published on Oriel and the JCST website. Review the person specification carefully.
January: Application window opens on Oriel. Applications are longlist-scored based on your portfolio evidence.
February: Application window closes. Shortlisting based on application scores.
March–April: Interviews take place. Usually in person at one or two national centres.
April–May: Offers made via Oriel.
August: ST3 posts commence.

Note: Timelines change year to year. Always check the JCST and Oriel websites for the definitive dates in the year you are applying. Do not rely on information from previous years.

The Person Specification — What They Are Looking For

The person specification for ST3 ENT is published annually by the JCST. It defines the minimum entry criteria (essential requirements that every applicant must meet) and the desirable criteria that differentiate candidates. Understanding the person specification and mapping your portfolio to it is the foundation of a successful application.

The domains typically scored are:

1. Qualifications

Essential: MB ChB / MB BS (or equivalent) and MRCS (Intercollegiate).
Desirable: Intercalated BSc (Hons), MD or PhD, additional degrees. Higher degree (MD/PhD) scores very well and demonstrates research commitment.

2. Clinical Experience

Essential: Evidence of clinical competence appropriate to CST level, a satisfactory ARCP at every stage, and demonstrated operative experience in a range of surgical procedures.
Desirable: Specific ENT clinical exposure during foundation or surgical training (ENT rotations, ENT taster weeks, ENT SHO/trust grade posts). The more ENT-specific your operative logbook, the better — include all ENT cases performed, even as assistant.
A dedicated year as a clinical fellow or trust grade doctor in ENT before applying is increasingly common and can significantly strengthen a portfolio.

3. Research, Audit, and Quality Improvement

Publications: Peer-reviewed publications in reputable journals score highly. A first-author original research paper in a PubMed-indexed journal is excellent. Case reports and review articles also count but score less.
Presentations: Oral and poster presentations at national and international meetings (ENT UK, British Association of Head and Neck Oncologists, Cochlear Implant Group, etc.) score well. Oral presentations at major national meetings score most highly.
Audit/QI: Must be able to demonstrate completed audit cycles (identifying a problem, measuring against a standard, implementing change, re-auditing). Quality improvement projects using formal QI methodology also score well.
MD/PhD: A completed higher research degree scores very highly and demonstrates sustained research commitment.

4. Teaching and Training

Evidence of formal teaching — tutorials, simulation, bedside teaching, undergraduate supervision.
Formal teaching qualifications (PgCert in Medical Education, AKT or equivalent) score well.
Involvement in medical student teaching, running simulation sessions, or contributing to educational resources.

5. Leadership, Management, and Teamwork

AOT (Association of Otolaryngologists in Training) involvement — committee membership, national audit lead, regional representative. The AOT is the national body for ENT trainees and active involvement is viewed very positively by interviewers.
Roles on junior doctor committees, BMA representation, college tutoring.
Evidence of leadership courses (NHS Leadership Academy programmes, Darzi Fellowship).
Formal management roles or experience in NHS management.

6. Courses and Additional Training

Basic surgical skills (BSS) and care of the critically ill surgical patient (CCrISP) courses — often essential by the time of application.
ENT-specific courses: temporal bone dissection courses, endoscopic sinus surgery courses, head and neck surgical anatomy courses. These are particularly valued for demonstrating ENT-specific commitment.
Advanced Life Support (ALS) provider status.
Good Clinical Practice (GCP) training if involved in clinical trials.

The Interview Format

The ST3 ENT interview typically consists of three stations, each lasting approximately 10–15 minutes. While the exact format is subject to change, the three domains assessed in recent years have been:

Portfolio Station: Assessors review your portfolio and application form, asking you to discuss and justify entries. They are looking for evidence of genuine achievement across all domains, consistency, and self-awareness about gaps.
Clinical Station: A clinical viva covering typical ENT on-call scenarios, outpatient management problems, and surgical decision-making. You may be shown images (e.g. an endoscopic image, an audiogram, a radiograph) and asked to interpret and manage.
Academic / Management Station: Questions about research methodology, critical appraisal, governance, leadership, ethics, and topical NHS issues. You may be asked about your own research or a recent important paper in ENT.

Clinical Viva — Common Questions with Model Answers

A patient calls the ENT emergency line with a 2-hour history of heavy epistaxis. How do you manage this?

Begin with an ABCDE assessment. Ask about the volume of bleeding, whether they are swallowing blood (indicates posterior bleed), current medications (particularly anticoagulants, antiplatelets, warfarin), and any relevant medical history. First-aid measures should have been attempted — ask the patient to sit forward, pinch the soft part of the nose (Kiesselbach's plexus), and apply cold compress. If the patient is coming in, ensure IV access and take bloods including FBC and coagulation screen in anticoagulated patients. On examination, identify the source if possible. The majority of nosebleeds arise from Little's area. Cauterise with silver nitrate if a clear bleeding point is identified. If cauterisation fails or the source is posterior, insert a Rapid Rhino or Merocel nasal pack. Anterior packs should be reassessed at 24–48 hours. Posterior bleeds may require formal balloon tamponade (e.g. Foley catheter) and consideration of admission. If packing fails, escalate to senior — sphenopalatine artery ligation or interventional radiology embolisation may be required. Always reverse reversible coagulopathy and review medications with medical colleagues.

You are the ENT SHO on call. A nurse calls to say a patient on the ward following a tonsillectomy 5 days ago has had a bleed. What do you do?

This is a secondary post-tonsillectomy haemorrhage — the most dangerous scenario in ENT. The immediate priority is airway assessment. Ask the nurse: is the patient conscious and maintaining their airway? Is there active bleeding? Go immediately. On assessment: is this a primary bleed (within 24 hours, usually surgical) or secondary (typically day 5–10, often infective)? Carry out ABCDE. Ensure two large-bore IV cannulae, bloods including FBC, coagulation screen, group and save (crossmatch if significant). Give IV crystalloid or blood products as needed. Examine the oropharynx with a good light — determine whether bleeding is ongoing or has stopped. Contact the anaesthetic registrar and the on-call ENT registrar/consultant immediately. Secondary bleeds require admission and observation as a minimum. If bleeding is ongoing, the patient may need to return to theatre for examination under anaesthetic and haemostasis. Even a small amount of blood in a child is concerning because they have a smaller circulating volume. Never underestimate a post-tonsillectomy bleed.

A patient is referred from A&E with stridor. Walk me through your approach.

Stridor is a medical emergency until proven otherwise. My priority is the airway. I will assess the patient immediately using ABCDE. Stridor is an upper airway noise indicating partial obstruction — inspiratory stridor suggests obstruction above the cords, expiratory suggests below, and biphasic (both phases) indicates obstruction at or near the cords. History: onset and progression (sudden versus gradual); associated symptoms (voice change, dysphagia, drooling, fever, neck swelling); relevant history including previous intubation, neck surgery, malignancy, foreign body. Examination: oxygen saturation, respiratory rate, work of breathing, voice quality. Do not examine the throat of a child with suspected epiglottitis — agitation can precipitate complete airway occlusion. Bloods and imaging: FBC, CRP; soft tissue neck X-ray (lateral) may show steeple sign (croup), thumbprint sign (epiglottitis), or radio-opaque foreign body. CT neck/thorax if malignancy or external compression is suspected. Key diagnoses: croup (most common in children, typically self-limiting, dexamethasone and nebulised adrenaline), epiglottitis (haemophilus influenzae, emergency — senior airway management in theatre), angioedema (IV hydrocortisone, adrenaline, antihistamine), vocal cord palsy, malignant obstruction. Alert anaesthetics and contact on-call consultant early — never manage a compromised airway alone as an SHO.

Tell me about your management of Bell's palsy.

Bell's palsy is an acute idiopathic lower motor neurone facial nerve palsy. The diagnosis is one of exclusion — first confirm it is a lower motor neurone (LMN) palsy (forehead involved) rather than an upper motor neurone (UMN) lesion (forehead spared, which suggests a central cause such as stroke and requires urgent CT/MRI). Grade severity using the House-Brackmann scale. Assess for any secondary features that would point to an alternative diagnosis: vesicles in the ear canal or pinna (Ramsay Hunt syndrome — herpes zoster oticus, requires antivirals plus steroids); parotid swelling (malignancy); associated neurological signs (Lyme disease, sarcoidosis, acoustic neuroma). Once Bell's palsy is confirmed, management is with oral prednisolone (50 mg daily for 10 days) started within 72 hours of onset — evidence supports steroids improving outcomes (Sullivan et al., Lancet 2007). Antivirals (aciclovir) remain controversial for Bell's palsy but are standard in Ramsay Hunt syndrome. Eye care is critical — incomplete eyelid closure risks corneal exposure injury. Prescribe lubricating eye drops and hypromellose eye ointment at night. Ophthalmology review if corneal involvement. Patients should be followed up to ensure recovery. Prognosis: 85% of patients have complete recovery without treatment. The addition of steroids improves this figure further. Incomplete or absent recovery at 6 months warrants re-evaluation.

Show me how you would interpret this audiogram [a standard four-frequency audiogram showing bilateral moderate sensorineural hearing loss is presented].

I would first identify the axes: the x-axis shows frequency in Hertz (Hz) from low (250 Hz) to high (8000 Hz), and the y-axis shows hearing level in decibels (dBHL), with 0 at the top (normal) and increasing loss downward. I note that this audiogram shows: air conduction thresholds (O for right ear, X for left) bilaterally at approximately 50–60 dBHL across the speech frequencies (500–4000 Hz). Bone conduction thresholds ([ for right, ] for left) are at approximately the same level, with no significant air-bone gap. This is consistent with a bilateral moderate sensorineural hearing loss. Key points: there is no conductive component (no ABG greater than 10–15 dBHL); the pattern is relatively flat across frequencies rather than showing high-frequency loss (which would suggest noise-induced or presbyacusis patterns) or a low-frequency dip (which might suggest Ménière's disease). In a patient of this age [hypothetical], I would want to know: any asymmetry (if greater than 10–15 dBHL at any frequency, an MRI of the IAMs is warranted to exclude a unilateral vestibular schwannoma); speech discrimination score; and impact on quality of life. This patient would benefit from a hearing aid trial and formal audiology assessment under NICE NG98 guidance. I would refer to audiology and, if asymmetric, additionally to ENT for further investigation.

Academic / Research Station — Common Questions

What is the difference between a randomised controlled trial and a cohort study? When would you use each?

A randomised controlled trial (RCT) is an interventional study in which participants are randomly allocated to receive either the intervention or a control (placebo or standard care). Randomisation is the key feature — it controls for both known and unknown confounders and allows causal inference to be drawn from the results. RCTs are considered the gold standard for evaluating the efficacy of a treatment. They are appropriate when you want to establish whether a specific intervention works, when equipoise exists, when the outcome can be measured in a reasonable timeframe, and when randomisation is ethically acceptable. A cohort study is an observational study following a group of people over time to see who develops the outcome of interest. It can be prospective or retrospective. It is appropriate for studying the natural history of a disease, identifying risk factors, or evaluating the impact of an exposure when an RCT is impractical (e.g. the effect of smoking on laryngeal cancer — you cannot randomise people to smoke). Cohort studies are susceptible to confounding, selection bias, and loss to follow-up. In terms of the hierarchy of evidence, systematic reviews and meta-analyses of RCTs sit above individual RCTs, which sit above cohort studies, which are above case-control studies and case series.

What is clinical governance and what are its main components?

Clinical governance is a framework through which NHS organisations are accountable for continuously improving the quality of their services and maintaining high standards of care by creating an environment in which clinical excellence will flourish. It was introduced following the Scally and Donaldson report of 1998 and became central to NHS policy following high-profile failures such as the Bristol heart surgery scandal. The main components — often summarised using the mnemonic PIRATES or similar — include: Patient and public involvement; Infection control and prevention; Risk management; Information management; Training and continuing professional development (CPD); Evidence-based practice and clinical audit; Staff management and performance. At the hospital level, clinical governance is overseen through clinical governance committees, Serious Incident reviews, and Morbidity and Mortality meetings (M&M meetings). The CQC's inspection framework assesses whether clinical governance structures are functioning effectively. For trainees, demonstrating awareness of and participation in clinical governance — through audit, incident reporting, M&M attendance, and reflection on learning from adverse events — is an important part of the portfolio.

Tell me about a significant development in ENT in the last five years and its implications.

[Example answer covering NICE NG34 tonsillectomy guidance]: One of the most discussed recent developments in ENT was the publication of the updated NICE NG34 guidance on tonsillitis in 2020, which applied strict criteria to the recommendation for tonsillectomy. The guidance concluded that tonsillectomy should only be offered when patients meet the Paradise criteria — at least 7 episodes of tonsillitis in the preceding year, 5 per year for 2 years, or 3 per year for 3 years. This created significant controversy because it was felt by many in the ENT community to be overly restrictive and not fully consistent with the ENT UK or SIGN guidelines. The practical implication was a reduction in GP referrals for tonsillectomy, which reduced waiting list pressure but also potentially denied the procedure to patients who would genuinely have benefited. The NATTINA trial (Lancet, 2019) found that tonsillectomy provided modest but statistically significant benefit in terms of quality of life and sore throat days per year. Understanding this kind of tension between guideline-driven care and individual clinical judgement is an important part of being a modern ENT surgeon.

Portfolio Station — What to Prepare

The portfolio station assessors will have reviewed your application form before you walk in. Their questions will probe the evidence behind each entry. Prepare to:

Discuss each publication: What was the question, what was the methodology, what were the findings and limitations? Can you defend the study design?
Discuss your audit: What was the standard you were auditing against? What change did you implement? Did you re-audit? What was the outcome?
Discuss your presentations: Where was the conference, what level was it (local, regional, national, international)? Was it oral or poster?
Discuss ENT-specific experience: How many ENT clinics? What operations have you performed or assisted with? What on-call experience do you have? Bring your logbook and be able to discuss cases.
Self-awareness: What are the weaknesses in your portfolio? What are you doing to address them? Interviewers respect honesty.

Professor Vik Veer's Top Tips

Top Tips from Prof Vik Veer

Start building your portfolio early. The biggest mistake trainees make is leaving portfolio activities to the last 6 months. Research, publications, and national presentations take years. Start in your foundation years and plan ahead.
Get ENT-specific experience. Many people applying for ST3 ENT have done very little ENT since medical school. A dedicated ENT trust grade or clinical fellowship post before applying makes a massive difference — both in portfolio terms and in your ability to answer clinical questions at interview.
Join the AOT. The Association of Otolaryngologists in Training is free to join, automatically confers membership, and offers opportunities for national audit involvement, educational events, and committee roles — all of which score in your portfolio. If you are serious about ENT, join now.
Do a temporal bone dissection course. These courses (available at the Royal College of Surgeons and several universities) are valued highly and demonstrate commitment to ENT surgical training. Book early as they are competitive.
Know your NICE guidelines. Be familiar with the key NICE guidelines relevant to ENT: NG215 (glue ear), NG34 (tonsillitis), NG98 (hearing loss), NG36 (head and neck cancer), NG12 (suspected cancer 2WW criteria). Being able to discuss these fluently in the academic station impresses interviewers.
Prepare for the clinical station systematically. Use the conditions covered on this website as a revision guide. Go through all the ENT on-call scenarios until you can talk through your management coherently and confidently under pressure.
Practice out loud. Being able to answer a question correctly in your head is different from being able to explain it clearly to an interviewer who may interrupt or challenge you. Practice with a friend, a registrar, or a consultant.
Know the current NHS landscape. Questions about NHS structure, governance, and recent policy changes (see the News section of this website) are common in the academic station. Know about NHS England's abolition, ICBs, the Shape of Training review, and the Francis Report at a minimum.

Frequently Asked Questions — ST3 ENT

What qualifications do I need to apply for ST3 ENT?

You must hold a primary medical degree (MB BS / MB ChB or equivalent), be fully registered with the GMC with a licence to practise, and have passed the Intercollegiate MRCS examination. You must also have completed or be about to complete a recognised Core Surgical Training (CST) programme (ST1–ST2) or equivalent, with a satisfactory ARCP at each stage. Many successful applicants also have additional qualifications such as an intercalated BSc, MD, or PhD, which score desirable points on the application form.

How competitive is the ST3 ENT application?

ST3 ENT is one of the more competitive surgical specialties. In recent years, competition ratios have typically been in the range of 3:1 to 6:1 (applicants per post). The number of posts varies from year to year. Competition is intense at both the application (longlist scoring) and interview stages. A strong portfolio with publications, national presentations, audit, ENT-specific experience, and relevant courses is essential to score highly enough to be invited to interview and to perform well at interview.

Do I need ENT-specific experience before applying for ST3 ENT?

While ENT-specific experience is not always an absolute requirement (depending on the person specification in a given year), it is strongly advisable and will significantly strengthen your application. Candidates who have worked in ENT — whether as an ENT trust grade doctor, clinical fellow, or through having an ENT rotation in their CST programme — are better able to answer clinical interview questions and have more ENT-specific operative logbook entries. Consider arranging a dedicated ENT post before applying if you have not yet had significant ENT exposure.

What should I include in my portfolio to maximise my interview score?

Key domains to focus on: (1) Research — aim for at least one first-author peer-reviewed publication, ideally in a PubMed-indexed ENT journal; (2) Presentations — national oral presentations score most highly; present at ENT UK annual meeting if possible; (3) Audit — ensure you have a completed audit cycle with demonstrable change; (4) Teaching — formal teaching experience with evidence; (5) ENT-specific experience — clinical exposure, operative logbook; (6) Courses — temporal bone dissection course, endoscopic sinus surgery course, ALS provider; (7) Leadership — AOT involvement, committee roles, management experience. An MD or PhD will score very highly if you have one.

What happens at the ST3 ENT interview?

The interview typically consists of three stations: a portfolio station (where assessors review your application and portfolio, asking you to discuss entries and evidence), a clinical viva station (covering ENT on-call scenarios, outpatient management, and image/audiogram interpretation), and an academic/management station (covering research methodology, governance, NHS issues, and topical ENT topics). Each station lasts approximately 10–15 minutes and is marked independently. You then receive an overall score, which is combined with your application/portfolio score to generate a ranked list for offer allocation.

What ENT clinical topics should I revise for the clinical station?

Focus on the ENT on-call scenarios most likely to be tested: management of epistaxis, post-tonsillectomy haemorrhage (primary and secondary), quinsy (peritonsillar abscess — diagnosis and drainage), stridor (causes and emergency management), Bell's palsy (diagnosis, grading, treatment), sudden sensorineural hearing loss (emergency investigation and management), vertigo (Ménière's versus BPPV versus labyrinthitis), auricular haematoma (drainage technique), nasal fractures (assessment and management), foreign bodies (ear, nose, throat). You should also know how to read an audiogram and tympanogram, and have a clear approach to a patient referred with a neck lump. All of these topics are covered in the ENT section of ClinicalJunior.com.

What NHS policy issues might come up in the academic/management station?

Be prepared to discuss: the abolition of NHS England (2025) and its implications; the structure of the NHS including Integrated Care Boards (ICBs); the Shape of Training review and how it changed surgical training pathways; the Francis Report and its impact on patient safety culture; the junior doctors pay dispute and its context; NICE guidance relevant to ENT (particularly NG34, NG215, NG98, NG36); clinical governance frameworks; and how to critically appraise a clinical paper. Demonstrating awareness of current events in the NHS shows you are an engaged professional, not just a technician.

How do I get onto the AOT and why does it matter?

The Association of Otolaryngologists in Training (AOT) is the UK body representing all ENT trainees and surgical trainees with an interest in ENT. Membership is free and automatic once you are on an ENT training programme. However, you can become involved as a pre-ST3 trainee by contacting the AOT and expressing interest in committee roles, national audit participation, or helping organise educational events. AOT involvement scores points in the leadership and management domain of the ST3 person specification. It also provides networking opportunities and keeps you informed about developments in ENT training. Their website is at aotent.com.

What is the FRCS (ORL-HNS) examination and when do I take it?

The Fellowship of the Royal Colleges of Surgeons in Otolaryngology, Head and Neck Surgery — FRCS (ORL-HNS) — is the exit examination for ENT specialty training in the UK. It is taken at the end of specialty training (typically at ST7–ST8 level, before CCT), not at entry to ST3. It consists of a written examination (Section 1) and an oral/clinical examination (Section 2). Passing FRCS (ORL-HNS) is required to obtain a CCT and to be eligible for a substantive consultant post in ENT. You do not need to have sat the FRCS to apply for ST3. Focus instead on passing MRCS and building your portfolio.

I did not get into ST3 ENT this year. What should I do?

This is more common than people think. First, request feedback from the deanery — most run a formal feedback process and this information is invaluable. Identify which domains scored poorly and make a structured plan to address them. Common reasons for not scoring high enough include: insufficient publications or presentations; incomplete audit cycles; limited ENT-specific experience; poor performance at interview (particularly in the clinical station). Consider taking an ENT clinical fellowship or trust grade post to build ENT experience and continue building your research portfolio. Many successful ST3 ENT trainees applied more than once. Use the extra time well.

ST3 ENT Specialty Training — Interview Preparation Guide